Progenics Announces Offer to Acquire EXINIOctober 20, 2015[caption id="attachment_1103" align="alignnone" width="4050"]
Ignyta Announces Issuance of Patent Covering Composition of Matter of RXDX-107October 20, 2015[caption id="attachment_1101" align="alignnone" width="1772"]
Concert Pharmaceuticals Highlights CTP-656 Phase 1 Results at North American Cystic Fibrosis ConferenceOctober 20, 2015[caption id="attachment_1099" align="alignnone" width="1200"]